Blood pressure response and renin release following 4 days of treatment with dihydralazine and urapidil in conscious dogs.
The magnitude and the persistence of blood pressure reduction by dihydralazine and urapidil were investigated following treatment over a period of 4 days. The experiments were performed on six normotensive dogs, trained to submit to puncture of the femoral artery and to stand quietly in a special frame. The first-dose effects of orally administered dihydralazine (1.42, 7.1 mg X kg-1) and urapidil (2.0, 10.0 mg X kg-1) on heart rate, arterial blood pressure and plasma renin activity (PRA) were compared with the effects of the substances after 4 days of treatment. Both compounds caused a dose-dependent decrease in blood pressure but in contrast to urapidil the effect of dihydralazine was accompanied by large increases in heart rate and PRA. Dose-dependent tolerance to dihydralazine but not to urapidil was observed after treatment over only 4 days. However, basal blood pressure was significantly lowered after 4 days of treatment with urapidil at the high dosage and no further reduction was achieved on the fifth day. The importance of persistent counterregulation in the development of tolerance to the antihypertensive effect of dihydralazine is discussed.
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects*; D004078:Dihydralazine / Q000494:pharmacology*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006830:Hydralazine / Q000031:analogs & derivatives*; D008297:Male; D010879:Piperazines / Q000494:pharmacology*; D012083:Renin / Q000097:blood*; D013997:Time Factors
D000959:Antihypertensive Agents; D010879:Piperazines; D006830:Hydralazine; C015568:urapidil; D012083:Renin; D004078:Dihydralazine